SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Akorn Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (97)8/25/2000 11:02:38 PM
From: John Metcalf  Read Replies (1) of 101
 
Sleep, sleep, sleep --

And then up 15% today. Yesterday Bausch and Lomb (BOL) guided earnings downward. Amongst other factors, they blamed shortfalls on generic competition, and said they would transition to higher-margined products.

BOL's statement could be understood to mean that companies like Akorn already have taken market share, and that they intend to walk away from competing in those niches. Sounds good to me!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News